Skip to content

HALO Signal / Watch™

See what changed. Decide what matters.

Connect a market observation to its source, possible significance and a considered next question.

Current availability: Demonstration. Monitoring requires qualified sources. Similarity is not an infringement finding; claims and rights require qualified review.

A small change. A consequential next question.

Product preview — not live

Know exactly what was seen.

Fictional source packaging specimen
Source specimen · not monitored evidence

See the difference, side by side.

Reference A: pale jar with a silver cap
Reference A Silver cap · pale jar
Reference B: green jar with a gold cap
Reference B Gold cap · green jar

Evidence before interpretation.

What changed?
Packaging
Colour and cap finish differ
Claim
No claim conclusion inferred
Formula
Cannot be inferred from a label

Route the finding to the right person.

Who should review?
Brand owner
Review differentiation
Product expert
Assess disclosed claims
Counsel
Review rights where relevant

Select a stage to inspect the example. No external action, product claim or business outcome is confirmed here.

HALO SIGNALPRODUCT VISION · DEMONSTRATION
PricingDemandMarket contextCompetitionPositioning
Observed changeExample competitor revises a product bundleSource needed
Commercial meaningCompare like-for-like value, not price aloneHypothesis
Recommended reviewValidate the offer and capture dated evidenceHuman review
Illustrative interface · not a connected service or customer result

Protect / Designed outputs

HALO Signal / Watch™

  • Source-linked commercial signals
  • Brand and product comparisons
  • Prioritised findings for qualified review

Connect observed changes to affected brands, products and markets. Preserve the evidence, uncertainty and recommended reviewer instead of turning similarity into an accusation.

Connection, review and activation requirements

External execution is not yet qualified. Public ingredient lists do not establish a complete formulation. Similarity does not establish copying, infringement, efficacy or safety.

  • Authorised public or licensed sources
  • Defined monitored assets and refresh policy
  • Qualified review and escalation ownership

Product access does not grant permission to execute. Identity, tenant, provider readiness and action scope are verified separately.